Changing the daily injection of glatiramer acetate to a monthly long acting product through designing polyester-based polymeric microspheres

Introduction: Glatiramer acetate (GA) is a newly emerged therapeutic peptide to reduce the frequency of relapses in multiple sclerosis (MS). Despite its good performance in controlling MS, it is not widely used due to daily or biweekly subcutaneous injections due to rapid degradation and body cleara...

Full description

Bibliographic Details
Main Authors: Fatima Molavi, Mohammad Barzegar-Jalali, Hamed Hamishehkar
Format: Article
Language:English
Published: Tabriz University of Medical Sciences 2022-11-01
Series:BioImpacts
Subjects:
Online Access:https://bi.tbzmed.ac.ir/PDF/bi-12-501.pdf

Similar Items